File Download
Patent History
- ApplicationCN 20048029686 2004-08-13
- PublicationCN 100549172 2009-10-14
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: Compositions and methods for prognosis and therapy of liver cancer
| Title | Compositions and methods for prognosis and therapy of liver cancer |
|---|---|
| Priority Date | 2003-08-13 US 10/494981P |
| Inventors | |
| Issue Date | 2009 |
| Citation | China Published Patent Application CN 100549172. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 How to Cite? |
| Abstract | This invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865), NDRG1 (AA486403), EST1 (H50345), TRPC1 (AA017132), GFRA1 (AA512935), EST2 (AA454543), CLDNIO (R54559), DNALII (R93087), RBP5 (AA453198), EST3 (AA621761) , EST4 (N63706), PCOLCE (AA670200), TD02 (T72398) , EST5 (T47454), HISTlH2BD (N33927), PXMP2 (N70714), ACAS2 (AA455146), ANAPC7 (T68445), EST6 (AA576580), RBP5 (N92148), ANXAl (H63077), CKB (AA894557), ITGBLl (N52533), KPNA2 (AA676460), EST7 (W90740) and MEG3 (W85841) This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy. |
| Persistent Identifier | http://hdl.handle.net/10722/176603 |
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2012-11-30T08:38:13Z | - |
| dc.date.available | 2012-11-30T08:38:13Z | - |
| dc.date.issued | 2009 | - |
| dc.identifier.citation | China Published Patent Application CN 100549172. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 | en_HK |
| dc.identifier.uri | http://hdl.handle.net/10722/176603 | - |
| dc.description.abstract | This invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865), NDRG1 (AA486403), EST1 (H50345), TRPC1 (AA017132), GFRA1 (AA512935), EST2 (AA454543), CLDNIO (R54559), DNALII (R93087), RBP5 (AA453198), EST3 (AA621761) , EST4 (N63706), PCOLCE (AA670200), TD02 (T72398) , EST5 (T47454), HISTlH2BD (N33927), PXMP2 (N70714), ACAS2 (AA455146), ANAPC7 (T68445), EST6 (AA576580), RBP5 (N92148), ANXAl (H63077), CKB (AA894557), ITGBLl (N52533), KPNA2 (AA676460), EST7 (W90740) and MEG3 (W85841) This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy. | en_HK |
| dc.title | Compositions and methods for prognosis and therapy of liver cancer | en_HK |
| dc.type | Patent | en_US |
| dc.description.nature | published_or_final_version | en_US |
| dc.contributor.inventor | Cheung, ST | en_HK |
| dc.contributor.inventor | Fan, ST | en_HK |
| patents.identifier.application | CN 20048029686 | en_HK |
| patents.identifier.application | ZL200480029686.1 | - |
| patents.description.assignee | UNIV HONG KONG [HK] | en_HK |
| patents.description.country | China, PRC | en_HK |
| patents.date.publication | 2009-10-14 | en_HK |
| patents.identifier.hkutechid | Surg-2003-00126-3 | - |
| patents.date.application | 2004-08-13 | en_HK |
| patents.date.priority | 2003-08-13 US 10/494981P | en_HK |
| patents.description.cc | CN | en_HK |
| patents.identifier.publication | CN 100549172 | en_HK |
| patents.relation.family | CN 1867671 (A) 2006-11-22 | en_HK |
| patents.relation.family | CN 100549172 (C) 2009-10-14 | en_HK |
| patents.relation.family | HK 1098783 (A1) 2010-07-02 | en_HK |
| patents.relation.family | US 2009325160 (A1) 2009-12-31 | en_HK |
| patents.relation.family | US 8076077 (B2) 2011-12-13 | en_HK |
| patents.relation.family | US 2005089895 (A1) 2005-04-28 | en_HK |
| patents.relation.family | WO 2005017150 (A1) 2005-02-24 | en_HK |
| patents.description.kind | C | en_HK |
| patents.type | Patent_published | en_HK |